Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Radiation: radiation therapy
Drug: lomustine
Drug: procarbazine hydrochloride
Drug: vincristine sulfate

First Posted Date: 2003-01-27

Last Posted Date: 2024-07-09

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 370

Registration Number: NCT00003375

Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas

Phase 3

Completed

Conditions: Pancreatic Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-11-19

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 518

Registration Number: NCT00003216

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
MBCCOP - Gulf Coast, Mobile, Alabama, United States
🇺🇸
CCOP - Greater Phoenix, Phoenix, Arizona, United States

and more 104 locations

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: tamoxifen citrate
Procedure: adjuvant therapy
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2022-05-25

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 636

Registration Number: NCT00003857

Locations: 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
🇺🇸
Arizona Oncology Services Foundation, Phoenix, Arizona, United States

and more 366 locations

Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer

Phase 3

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Radiation: Standard fractionation RT
Radiation: Accelerated fractionation radiation therapy
Procedure: Conventional surgery for select patients

First Posted Date: 2003-01-27

Last Posted Date: 2023-07-07

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 743

Registration Number: NCT00047008

Locations: 🇺🇸
Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States

and more 192 locations

Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer

Phase 2

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: cisplatin
Drug: paclitaxel
Procedure: conventional surgery
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 70

Registration Number: NCT00011999

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
Huntsville Hospital System, Huntsville, Alabama, United States

and more 231 locations

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: bicalutamide
Drug: docetaxel
Drug: doxorubicin hydrochloride
Drug: estramustine phosphate sodium
Drug: flutamide
Drug: ketoconazole
Drug: paclitaxel
Drug: releasing hormone agonist therapy
Drug: vinblastine sulfate

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 21

Registration Number: NCT00030654

Locations: 🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States
🇺🇸
Veterans Affairs Medical Center - Little Rock, Little Rock, Arkansas, United States

and more 75 locations

Melatonin and Radiation Therapy in Treating Patients With Brain Metastases

Phase 2

Completed

Conditions: Metastatic Cancer
Radiation Toxicity
Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00031967

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
MBCCOP - Gulf Coast, Mobile, Alabama, United States

and more 231 locations

Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer

Phase 3

Completed

Conditions: Anemia
Head and Neck Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00004917

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
Huntsville Hospital System, Huntsville, Alabama, United States

and more 258 locations

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Drug: temozolomide
Procedure: neoadjuvant therapy
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 42

Registration Number: NCT00033280

Locations: 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States

and more 36 locations

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

Phase 3

Completed

Conditions: Endometrial Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00006027

Locations: 🇺🇸
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
🇺🇸
Community Hospital of Los Gatos, Los Gatos, California, United States
🇺🇸
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center, Orange, California, United States

and more 26 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy